Statistics

Total Visits

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study68

Select a period of time:

Number of views in the range

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study41

Views

Views
April 20252
May 20253
June 202510
July 202514
August 20251
September 202511
October 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Hong Kong10
Brazil3
United Kingdom2
Argentina1
Canada1
Germany1
Ecuador1
Spain1
Ireland1
 

Top cities views

Views
Hong Kong10
Dallas7
Alton1
Angatuba1
Aurora1
Barreiras1
Battle Creek1
Catanduva1
Council Bluffs1
Dakar1